2-month HIV injection could be on its way, as ViiV touts new dual-drug win

22nd August 2019 Uncategorised 0

Imagine HIV patients needed to take their antiretroviral therapies not every day, not even every month, but every two months. A GlaxoSmithKline two-drug injectable regimen that’s already under review by the FDA for monthly use could soon turn it into reality, thanks to a phase 3 win.

More: 2-month HIV injection could be on its way, as ViiV touts new dual-drug win
Source: fierce